Search research articles
Contact Us
Filters
Showing results (1-10 of 165) with videos related to
Page
of 17
Sort By:
Annals of the Rheumatic Diseases
|
August 14, 2020
Glucosamine and mortality: a note of caution
Richard Conway
The New England Journal of Medicine
|
October 21, 2020
Allopurinol and Chronic Kidney Disease
Richard Conway
The Journal of Rheumatology
|
June 4, 2013
The real world of gout
Richard Conway
Blood
|
August 25, 2022
Ruxolitinib takes center stage for VEXAS syndrome
Richard Conway
ACR Open Rheumatology
|
May 17, 2023
Clinical Image: Antineutrophil cytoplasmic antibody-associated vasculitis causing compressive cervicothoracic myelopathy
Patricia Harkins, Richard Conway
Rheumatology (Oxford, England)
|
October 17, 2020
Treating interstitial lung disease in rheumatoid arthritis - the embers of hope
Richard Conway, Elena Nikiphorou
Therapeutic Advances in Musculoskeletal Disease
|
February 26, 2019
Current advances in the treatment of giant cell arteritis: the role of biologics
Candice Low, Richard Conway
Expert Opinion on Investigational Drugs
|
June 9, 2021
Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?
Patricia Harkins, Richard Conway
Women'S Health (London, England)
|
January 11, 2023
Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
Candice Low, Richard Conway
European Journal of Internal Medicine
|
July 24, 2021
Comment to: Non-specific clinical presentations are not prognostic and do not anticipate hospital length of stay or resource utilization: Author's reply
Richard Conway, Bernard Silke
Page
of 17
Search research articles
Search
Showing results (1-10 of 165) with videos related to
Sort By:
Page
of 17
Annals of the Rheumatic Diseases
|
August 14, 2020
Glucosamine and mortality: a note of caution
Richard Conway
The New England Journal of Medicine
|
October 21, 2020
Allopurinol and Chronic Kidney Disease
Richard Conway
The Journal of Rheumatology
|
June 4, 2013
The real world of gout
Richard Conway
Blood
|
August 25, 2022
Ruxolitinib takes center stage for VEXAS syndrome
Richard Conway
ACR Open Rheumatology
|
May 17, 2023
Clinical Image: Antineutrophil cytoplasmic antibody-associated vasculitis causing compressive cervicothoracic myelopathy
Patricia Harkins, Richard Conway
Rheumatology (Oxford, England)
|
October 17, 2020
Treating interstitial lung disease in rheumatoid arthritis - the embers of hope
Richard Conway, Elena Nikiphorou
Therapeutic Advances in Musculoskeletal Disease
|
February 26, 2019
Current advances in the treatment of giant cell arteritis: the role of biologics
Candice Low, Richard Conway
Expert Opinion on Investigational Drugs
|
June 9, 2021
Giant cell arteritis: what is new in the preclinical and early clinical development pipeline?
Patricia Harkins, Richard Conway
Women'S Health (London, England)
|
January 11, 2023
Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
Candice Low, Richard Conway
European Journal of Internal Medicine
|
July 24, 2021
Comment to: Non-specific clinical presentations are not prognostic and do not anticipate hospital length of stay or resource utilization: Author's reply
Richard Conway, Bernard Silke
Page
of 17